Skip to main content
. 2026 May 20;21(1):208. doi: 10.1186/s11671-026-04651-1

Table 3.

Different types of nanocarriers, their advantages and limitations, targeting strategies are briefly discussed in the following tabular format

Nanocarrier Typical materials Targeting mechanism Advantages Limitations References
Lipid vesicles Phospholipids, Cholesterol Pegylation, Antibodies, pH-sensitive lipids High biocompatibility, biodegradable carry drugs Poor encapsulation of hydrophobic drugs, physical instability and high production costs [66]
Polymer NPs PEG, Chitosan Folic acid, peptides, aptamers, pH-responsive High stability, control release, versatile surface modification Potential toxicity of non-biodegradable polymers [67]
Polymer Micelles Au, FeO, Mesoporous Silica Antibodies, and aptamers Excellent for poorly soluble hydrophobic drugs, low CMC confirms stability in blood Break apart if diluted below CMC in blood, limited drug loading capacity [68]
Solid Lipid NPs Lipid polymer, Inorganic-polymer Stimuli-responsive ligand surface modification High lipophilic drug loading capability and avoids organic solvents stability Limited drugs loading capacity, risk of drug leakage during storage due to change the structural moiety [64]
Dendrimers Polylysine, PMMA Surface-modified targeting ligands, peptides Well-developed 3D structure, high surface functionality, size control High production cost, and potential for toxicity [71]
Gold NPs Amphiphilic block and random copolymers Target-specific ligands, pH-sensitive, tumor microenvironment Excellent optical properties for imaging therapy, high stability Generally poor drug loading capacity, potential long-term cytotoxicity [95]
Magnetic NPs Natural cell-derived vesicles Integrins surface receptors, cell-specific modification External magnetic field used for MRI contrast and medicinal therapy Potential toxicity tendency requires for protective coating [96]
Cholic acid Micelles Amphiphilic block copolymers Target-specific ligands, pH-sensitive, Tumor microenvironment Hydrophobic drug delivery, Cancer therapy High production cost, and potential for toxicity [14]
Exosomes Natural cell-derived vesicles Surface receptors modification Targeted drug delivery, Break apart at below CMC in blood, and limited drug loading capacity [97]